Faulty hormone receptor tests disqualified scores of women in Newfoundland and Labrador from receiving potentially life-saving treatment for breast cancer, court documents show.

• 法院文件显示，纽芬兰和拉布拉多的数十名妇女因不完善的激素受体测试而丧失了获得可能的针对乳腺癌的挽救生命性的治疗的资格。